Ruijie Zeng
- Rehabilitation top 10%
-
- Gastroesophageal reflux and treatments 4
-
- Protein Kinase Regulation and GTPase Signaling 4
- Gut microbiota and health 4
-
- Esophageal Cancer Research and Treatment 6
- Helicobacter pylori-related gastroenterology studies 6
-
- Cancer Immunotherapy and Biomarkers 6
-
- Inflammatory Bowel Disease 5
-
- COVID-19 Clinical Research Studies 3
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ruijie Zeng
46 papers receiving 725 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Rehabilitation 72
- Cancer Research 105
- Biomaterials 74
- Gastroenterology 28
- Molecular Biology 318
Countries citing papers authored by Ruijie Zeng
This map shows the geographic impact of Ruijie Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijie Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijie Zeng more than expected).
Fields of papers citing papers by Ruijie Zeng
This network shows the impact of papers produced by Ruijie Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijie Zeng. The network helps show where Ruijie Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruijie Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 18 | |
| 6 | 2024 | 4 | |
| 7 | Stomach microbiota in gastric cancer development and clinical implicationsbreakdown → | 2024 | 50 |
| 8 | 2024 | 15 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 19 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2022 | 8 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 6 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 30 | |
| 20 | 2020 | 16 |
About Ruijie Zeng
Ruijie Zeng is a scholar working on Gastroenterology, Oncology and Surgery, having authored 55 papers that have together received 737 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Inflammatory Bowel Disease (5 papers), Gastroesophageal reflux and treatments (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Gut microbiota and health (4 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Rehabilitation (72 citations), Cancer Research (105 citations) and Biomaterials (74 citations). Ruijie Zeng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weihong Sha, Zewei Zhuo, Hao Chen, Chunwen Zheng, En‐Min Li, Huihuan Wu, Jun Yu, Harry Cheuk-Hay Lau, Li‐Yan Xu and Hongyan Gou. Their work appears in journals such as International Journal of Surgery, EClinicalMedicine, eLife, Food Chemistry X and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.